Lezack Adam's Form 4 filing
Beta Bionics, Inc.BBNX · filed May 26, 2026
- Accession no.
- 0002048466-26-000003
- Filed
- May 26, 2026
- Trade date
- May 21-22, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $21.1K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lezack AdamCIK 0002048466 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2026 | Common Stock | SSaleDisposed | −1,000 | $9.95 | −$9,950 | 11,432 | Direct | |
| May 21, 2026 | Common Stock | AGrant or awardAcquired | +16,965 | $0.00 | $0 | 28,397 | Direct | |
| May 22, 2026 | Comon Stock | SSaleDisposed | −998 | $11.21 | −$11,187.58 | 27,399 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.